China Healthwise Holdings Limited (HKG:0348)

Hong Kong · Delayed Price · Currency is HKD

0.0700

+0.0010 (1.45%)

Sep 11, 2026, 3:29 PM HKT

China Healthwise Holdings Financials Overview

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	84.97	99.56	113.58	146.32	142.06	170.08
Revenue Growth	-14.66%	-12.34%	-22.38%	3.00%	-16.48%	23.38%
Gross Profit	21.7	36.62	35	-47.18	28.49	-11.61
Operating Income	-27.4	-12.63	-20.45	-112.58	-38.39	-75.79
Net Income	-33.12	-2.61	-40.28	-134.56	-54.27	-103.05
Earnings Per Share	-0.04	-0.00	-0.05	-0.17	-0.07	-0.13
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Money Lending Business	0.59	0.61	1.13	10.66	14.63	22.29
Chinese Health Products	96.13	99.2	112.83	129.52	128.38	114.2
Investment in Financial Instruments	-11.76	-0.25	-0.39	6.14	-0.95	33.59
Total	84.97	99.56	113.58	146.32	142.06	170.08

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	25.49	66.16	48.15	59.16	78.73	101.62
Total Debt	94.61	106.13	103.74	108.9	109.9	90.86
Net Cash (Debt)	-69.12	-39.98	-55.59	-49.74	-31.17	10.76
Net Cash Growth	-	-	-	-	-	-65.68%
Net Cash Per Share	-0.09	-0.05	-0.07	-0.06	-0.04	0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	15.05	3.13	14.49	-28.34	42.08
Capital Expenditures	-	-0.09	-0.26	-0.19	-0.63	-0.36
Free Cash Flow	-	14.96	2.87	14.3	-28.97	41.72
Free Cash Flow Growth	-	420.36%	-79.90%	-	-	458.39%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	25.54%	36.78%	30.82%	-32.24%	20.05%	-6.83%
Operating Margin	-32.25%	-12.68%	-18.01%	-76.94%	-27.02%	-44.56%
Pretax Margin	-41.38%	-3.31%	-35.24%	-90.26%	-39.70%	-59.14%
Profit Margin	-38.98%	-2.62%	-35.47%	-91.96%	-38.21%	-60.59%
FCF Margin	-	15.02%	2.53%	9.77%	-20.39%	24.53%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
P/FCF Ratio	-	7.01	41.55	2.21	-	5.17
PS Ratio	0.76	1.05	1.05	0.22	1.02	1.27